Rehabilitation in Patients With Human Lymphotropic Virus Type I
Human T-Lymphotropic Virus Type 1 Associated Myelopathy
About this trial
This is an interventional treatment trial for Human T-Lymphotropic Virus Type 1 Associated Myelopathy
Eligibility Criteria
Inclusion Criteria:
- Seropositive carriers for HTLV-1 with PET
Exclusion Criteria:
- lung diseases
- heart disease
- arterial hypertension
- cognitive impairments
Sites / Locations
- Universidade do Estado do ParáRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Respiratory muscle training group
Aerobic exercise group
Inspiratory muscle training with linear load device, associated with the resisted training. The initial training load for each participant will be adjusted to 25% of MIP. Each week, the researcher determines the new values for load (1 to week 25%, 2 to week 35%;. 3 to week 40%;. 4 to week 45%;. 5 to week 50%.).The resistance training protocol will consist of the exercises of the front pull, the extension chair and the vertical bench press, covering large muscle groups in the dorsal region of the quadriceps and chest, respectively. Each year consist of three sets of 10 repetitions with a load equivalent to 60% of a test Repetition Maximum (1RM), which will be changed every week (1 to week 60%, 2 to week 65%;. 3 the . week 70%, 4 to week. 75%, 5 to week 80%).
Exercise bike for 30 minutes, which will be divided into 10 minutes for the foot heating and 20 minutes for the workout aerobic exercise that will have to maintain a target training heart rate, training has to be equivalent to 40% to 60%% target intensity.